Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Class Action Lawsuit Aims to Halt GSK Acquisition of Tesaro

GlaxoSmithKline announced plans to acquire Tesaro for $5.1 billion in December 2018. Shareholders have filed for a class action lawsuit against Tesaro in Delaware federal court, alleging that the merger is based on misleading financial analyses filed with the U.S. Securities and Exchange Commission.

Read More »

Pfizer to shut two manufacturing plants in India

U.S. drugmaker Pfizer Inc. said the company was shutting down two manufacturing plants in India that make generic injectables such as penicillin in response to falling demand.

Read More »

Akorn gets FDA warning letter for Illinois plant

Akorn Inc. received a warning letter from the U.S. Food and Drug Administration following an inspection of the generic drugmaker’s Decatur, Illinois manufacturing plant during 2018.

Read More »

U.S. health-care industry spends $30 billion a year on marketing

Spending on health-care advertising in the United States almost doubled over the past two decades as companies compete for their share of the world’s largest healthcare market, a U.S. study suggests.

Read More »

New York City launches $100 million universal health insurance program

New York City launched a $100 million health insurance program to cover 600,000 uninsured residents, including those unable to afford coverage and those living in the United States illegally.

Read More »

GlaxoSmithKline to look for early-stage assets: CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker’s chief executive officer said.

Read More »

GlaxoSmithKline, Teva, Takeda Investing in Global Sustainability Performance with the Responsible Health Initiative

Three leading health and pharmaceutical companies – GlaxoSmithKline, Teva, Takeda – and EcoVadis, the leading provider of sustainability risk and performance ratings for global supply chains, announced the launch of the Responsible Health Initiative.

Read More »

Gilead Inks $785 Million Deal With Yuhan

Gilead Sciences Inc. is acquiring the global rights to develop and commercialize novel small molecules against two targets from South Korea-based Yuhan Corporation.

Read More »

Top 20 Life Science Startups to Watch in 2019

BioSpace presented the NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched no earlier than 2017. According to BioSpace, the companies are already making an enormous impact on the industry and will continue to do so into the future.

Read More »

U.S. Supreme Court could side with Merck over Fosamax lawsuits

U.S. Supreme Court justices appeared sympathetic to Merck & Co. in the company’s bid to fend off hundreds of lawsuits accusing the company of failing to adequately warn patients of the risks of thigh bone fractures associated with the osteoporosis drug Fosamax.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!


Ad Right Bottom